Oncology Business Management | Specialty

Tools to Help Patients Navigate Their Treatment Path

March 7th 2011

Monica Knoll is no stranger to cancer. Her sister is a breast cancer survivor and her father died from esophageal cancer. Still, she was not prepared for a breast cancer diagnosis in 2000

Understanding the Implications of Mandatory Vendor Imposition in Oncology

March 5th 2011

The rising costs of healthcare have caused payers to analyze spending and take measures to contain costs.

Biomarkers in Ovarian Cancer: Early Detection and Chemoresistance

March 4th 2011

Worldwide, there are ~204,000 new cases of ovarian cancer each year, accounting for 4% of cancers diagnosed in women.

Summer FDA Updates

March 4th 2011

FDA updates from the summer of 2010

Fall FDA Updates

March 4th 2011

Further Winter 2010 FDA Updates

March 3rd 2011

Winter 2010 FDA Updates

March 3rd 2011

FDA updates from Winter 2010

Cancer in the Workplace

March 2nd 2011

As the number of cancer survivors grows, the disease has emerged as a greater concern for companies anxious to meet the needs of employees and their families while still operating their businesses in an efficient and cost-effective manner.

Medical Marijuana Is a Trojan Horse That Pain Physicians Should Refuse to Accept

March 2nd 2011

Forty-six percent of Americans want marijuana to be legalized. Seventy percent of Americans support the legalization of medical marijuana.

Net Guides: Oral Cancer

December 16th 2010

Useful Online Resources and Clinical Trials for Oral Cancer

Payers Try to Drive Down Costs in Cancer Care

November 8th 2010

Steadily rising expenses and a proliferation of new drugs are speeding adoption of a host of measures designed to contain drug and treatment outlays more directly

BIO-BUZZ: Inhibition of Angiogenesis with Bevacizumab Shows Promise in the Treatment of Recurrent or Advanced Non%u2013Small-Cell Lung Cancer

August 17th 2010

This year in the US, the American Cancer Society estimates that lung cancer will kill more people than breast, prostate, colon, liver, and kidney cancers combined, making it the leading cause of cancer death among Americans.

The Industry Insider: March 2007

August 17th 2010

Additional breaking news from the biotech industry. In this issue: 1) FDA OKs Ikonisys' Bladder Cancer Test 2) Good News From China for Peregrine 3) Introgen Sees Advances on Two Fronts 4) Debiopharm Procures Cancer Therapy from Kirin Brewery

Flash Findings

August 17th 2010

Fast biotech facts and figures. In this issue: 1) Cancer Risk Factors and Mortality 2) Bladder Cancer 3) Testicular Cancer 4) Breast Cancer

The Academy: March 2007

August 17th 2010

The Academy delivers the latest news on biotech and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery.

Politics & Policy: March 2007

August 17th 2010

The Politics and Policy page provides a concise and timely round-up of key government-related oncology and biotechnology news. Content is focused upon the public sector activities that are most likely to impact the evolving oncology and biotech industries.

Immunotherapy

August 16th 2010

Novel immunotherapy approaches to metastatic prostate cancer: Stimulating the immune response ex vivo with autologous antigen presenting cells.

The A-Z Business Wire

August 16th 2010

The latest business and financial biotech news. In this issue: 1) Adherex Buys Back GSK%u2019s Rights to Failed Cancer Drug 2) Archemix and Merck Partner on Aptamer-Based Cancer Therapeutics, and more

The Virtual Window: Clinical Trial Reports--March 2007

August 16th 2010

Successful research into new therapies for cancer requires a ready supply of patients willing to participate in clinical trials, and physicians and other health care professionals who will refer their patients to the appropriate studies.

News Reports; March 2007

August 16th 2010

News items reported in this issue: 1) 186-Gene Signature in Cancer Stem Cells Predicts Recurrence 2) National Prostate Cancer Coalition Commences Clinical Trial Education Program 3) Concomitant High-Dose Radiation Therapy Plus Cetuximab Improves Locoregional Control and Reduces Mortality, with No Increase in Radiation Therapy%u2013Associated Toxicity in Patients with Advanced Squamous-Cell Carcinoma of the Head and Neck, and more